Junghänel, Michaela
Wand, Hildegard
Dose, Christina
Thöne, Ann-Kathrin
Treier, Anne-Katrin
Hanisch, Charlotte
Ritschel, Anne
Kölch, Michael
Lincke, Lena
Roessner, Veit
Kohls, Gregor
Ravens-Sieberer, Ulrike
Kaman, Anne
Banaschewski, Tobias
Aggensteiner, Pascal-M.
Görtz-Dorten, Anja
Döpfner, Manfred
Bernheim, Dorothee
Bienioschek, Stefanie
Boecker, Maren
Brandeis, Daniel
Christmann, Nina
Daunke, Andrea
Fegert, Jörg M.
Frenk, Franziska
Giller, Franziska
Ginsberg, Claudia
Goldbeck, Carolina
Groh, Monja
Hellmich, Martin
Hohmann, Sarah
Holz, Nathalie
Igel, Christine
Kaiser, Anna
Katmer-Amet, Betül
Katzmann, Josepha
Millenet, Sabina
Mücke, Kristina
Schreiner, Anne
Schroth, Jennifer
Schüller, Anne
Steiner, Marie-Therese
Steiner, Marion
Uhlmann, Anne
Winkler, Matthias
Zaplana, Sara
,
Funding for this research was provided by:
German Federal Ministry of Education and Research (FKZ01GL1741D)
Universitätsklinikum Köln
Article History
Received: 18 July 2022
Accepted: 30 November 2022
First Online: 22 December 2022
Declarations
:
: Approval was obtained from the ethics committee of the University of Cologne (18–033), the University Hospital of Dresden (EK 35409218), the University Hospital of Mannheim (2018-554 N-MA) and the University Hospital of Ulm (297/18). The procedures used in this study adhere to the tenets of the Declaration of Helsinki.
: Not applicable.
: Tobias Banaschewski served in an advisory or consultancy role for ADHS digital, Infectopharm, Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Roche, and Takeda. He received conference support or speaker’s fees from Medice and Takeda. He received royalities from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press; the present work is unrelated to these relationships. Daniel Brandeis served as an unpaid scientific advisor for an EU-funded neurofeedback trial unrelated to the present work. Manfred Döpfner receives royalties from publishing companies as an author of books and treatment manuals on child behavioral therapy and of assessment manuals published by Beltz, Elsevier, Enke, Guilford, Hogrefe, Huber, Kohlhammer, Schattauer, Springer, and Wiley. He receives income as a consultant for Child Behavior Therapy at the National Association of Statutory Health Insurance Physicians. He also receives consulting income and research support from Lilly, Medice, Takeda, and eyelevel GmbH. Jörg Fegert received research funding from EU, BMG (Federal Ministry of Health), BMBF (Federal Ministry of Education and Research), BMFSFJ (Federal Ministry of Family, Senior Citizens, Women and Youth), DFG (German Research Foundation), G-BA Innovation Fund, State Ministries of Baden-Württemberg and Saarland, State Foundation Baden-Württemberg, Porticus Foundation, Evangelical-Lutheran Church in Württemberg. He received travel grants, honoraria, sponsorship for conferences and medical educational purposes from APK, Adenauer- and Ebertstiftung, Deutschlandfunk, DFG, DJI, DKSB, Infectopharm, med update, UNICEF, professional associations, universities and federal and state ministries. He is a consultant for APK, federal and state ministries. He has no industry-sponsored lecture series, no shareholdings, no participation in pharmaceutical companies. Anja Görtz-Dorten receives royalties from publishing companies as an author of books and treatment manuals on child behavioral therapy and assessment manuals, including the treatment manuals evaluated in this trial. She receives income as a consultant for Child Behavior Therapy at the National Association of Statutory Health Insurance Physicians. She also receives consulting income and research support from Medice and eyelevel GmbH. Charlotte Hanisch receives royalties from a publishing company as the author of a treatment manual. Martin Hellmich receives consulting income from eyelevel GmbH. Josepha Katzmann receives royalties from a publishing company as author of two self-help books on child behavioral therapy. Michael Kölch receives royalties from publishing companies as an author of books. He served as PI or CI in clinical trials of Lundbeck, Pascoe and Janssen-Cilag. He served as scientific advisor for Janssen. The present work is unrelated to the above grants and relationships. Veit Roessner has received lecture honoraria from Infectopharm and Medice companies. He has carried out clinical trials in cooperation with Servier and Shire Pharmaceuticals/Takeda companies. The present work is unrelated to the above grants and relationships. All other authors have no competing interest to declare.